These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 5708894)

  • 1. On the nature of antithrombin V.
    Vinazzer H; Reinhardt F
    Thromb Diath Haemorrh; 1968 Nov; 20(1):234-46. PubMed ID: 5708894
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences in the effect of antithrombin on thrombin clotting and thrombin esterase activity.
    Gans H; Boulton A
    Thromb Diath Haemorrh; 1969 Aug; 22(1):28-31. PubMed ID: 5821245
    [No Abstract]   [Full Text] [Related]  

  • 3. Coagulation studies of the vascular intima. II. Antithrombin activity.
    Oe K
    Nihon Ketsueki Gakkai Zasshi; 1969 Apr; 32(2):297-310. PubMed ID: 5388239
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antithrombin V--a rare concomitant symptom in plasmacytoma and autoimmune diseases].
    Lutze G; Dieckmann U; Franke A; Mittler U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(2):278-92. PubMed ID: 6194061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ISOLATION AND PROPERTIES OF ANTICOAGULANTS FROM FIBRINOLYSED AND HUMAN HEART-PUMP PLASMAS.
    TRIANTAPHYLLOPOULOS DC; TRIANTAPHYLLOPOULOS E
    Can J Physiol Pharmacol; 1964 Mar; 42():169-87. PubMed ID: 14329312
    [No Abstract]   [Full Text] [Related]  

  • 6. [Identification of antithrombin V and its behavior in the plasma and serum of the newborn infants and adults].
    Brüster H; Sturm H
    Z Kinderheilkd; 1966; 95(1):24-8. PubMed ID: 5983598
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding.
    Schols SE; van der Meijden PE; van Oerle R; Curvers J; Heemskerk JW; van Pampus EC
    Thromb Haemost; 2008 Jan; 99(1):64-70. PubMed ID: 18217136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lengthening of the thrombin time due to an anti-equine antithrombin in a case of hyperthrombocytic myelosis].
    Favre-Gilly J; Thouverez JP; Belleville J; Croizat P
    Lyon Med; 1966 May; 215(20):1351-5. PubMed ID: 5932766
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemostasis in plasmocytomas. Preliminary observations on the inhibiting activities demonstrable in the plasma and serum protein fractions.
    Recalcati P; Besana C; Ballarino M
    Haematol Lat; 1967; 10(4):317-35. PubMed ID: 5597878
    [No Abstract]   [Full Text] [Related]  

  • 10. On the reliability of the use of heparin immobilized on agarose for the study of the interactions among heparin, thrombin and antithrombin.
    Fish WW; Björk I
    Thromb Haemost; 1982 Aug; 48(1):84-6. PubMed ID: 7135347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [EVALUATION OF THE ANTITHROMBIN TEST AND THE STARCH TOLERANCE TEST IN THE DIAGNOSIS OF PANCREATIC DISEASES].
    KUBICKI S; LATALLO Z; KACNER J; DOROBA K; WASILEWSKA H
    Pol Tyg Lek; 1964 Oct; 19():1593-6. PubMed ID: 14328847
    [No Abstract]   [Full Text] [Related]  

  • 12. [Circulating heparinoid anticoagulant (antithrombin II). Report of a fatal case and review of the problem].
    Goldstein C; Sumoza A; De Bosch N; De Sanz N
    Sangre (Barc); 1973; 18(3):313-21. PubMed ID: 4757640
    [No Abstract]   [Full Text] [Related]  

  • 13. [Behavior of thrombin time, activities of antithrombin II and 3 following administration of cobalt (II) compounds in rabbits].
    Wohllebe W; Taube C; Fiedler H
    Z Gesamte Inn Med; 1968 Sep; 23(17):537-9. PubMed ID: 5715725
    [No Abstract]   [Full Text] [Related]  

  • 14. Assay of progressive antithrombin in plasma.
    Abildgaard U; Gravem K; Godal HC
    Thromb Diath Haemorrh; 1970 Oct; 24(1):224-9. PubMed ID: 5483962
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in thrombin generation and antithrombin titer following massive bleeding and transfusion in dogs.
    MONKHOUSE FC; MILOJEVIC S
    Can J Biochem Physiol; 1960 May; 38():475-80. PubMed ID: 14423574
    [No Abstract]   [Full Text] [Related]  

  • 16. Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature.
    Zürcher M; Sulzer I; Barizzi G; Lämmle B; Alberio L
    Thromb Haemost; 2008 Feb; 99(2):416-26. PubMed ID: 18278194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exchange transfusion activates coagulation and alters the coagulation profile in newborn infants.
    Långström S; Wartiovaara-Kautto U; Andersson S; Heikinheimo M; Petäjä J
    Thromb Haemost; 2006 Aug; 96(2):142-8. PubMed ID: 16894456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombin deficiency increases thrombin activity after prolonged cardiopulmonary bypass.
    Sniecinski R; Szlam F; Chen EP; Bader SO; Levy JH; Tanaka KA
    Anesth Analg; 2008 Mar; 106(3):713-8, table of contents. PubMed ID: 18292407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Method of determining total antithrombin activity, antithrombins II, 3 and IV].
    Babich VP; Byshevskii ASh
    Lab Delo; 1972; 8():467-70. PubMed ID: 4124339
    [No Abstract]   [Full Text] [Related]  

  • 20. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
    Rezaie AR
    Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.